CRM foundation
DOSSIRI is positioned as a CRM-first workspace for account records, contacts, deals, tasks, evidence, and timeline memory.
- Account workspace
- Contacts
- Deals
- Tasks
- Evidence records
- Timeline memory
DOSSIRI is currently in early access. Public pricing, plan packaging, subscription billing, and feature availability rules have not been published yet.
Request early access for launch updates. No credit card is requested on the early access form.
DOSSIRI is positioned as a CRM-first workspace for account records, contacts, deals, tasks, evidence, and timeline memory.
DOSSIRI intelligence is described as account-context enrichment inside the CRM workflow, not as a separate entitlement promise.
The current website supports early access requests while final pricing, billing flows, and launch packaging are still being prepared.
Questions about DOSSIRI? Here are answers to some of the most common questions we receive.
No. Public pricing has not been published yet. DOSSIRI is currently collecting early access requests while launch packaging is prepared.
Not through this website today. The current call to action is to request early access; it is not a self-serve trial, checkout, or subscription signup.
No. This page describes product areas at a high level. It does not define final plan limits, billing tiers, subscription entitlements, or feature availability rules.
The marketing website does not advertise live subscription checkout, Stripe checkout, self-serve billing management, or automated plan changes. Billing details are still being prepared.
DOSSIRI is a CRM first. Intelligence exists to enrich CRM workflows, not replace them.
DOSSIRI is built for life sciences and regulated-industry sales professionals, including CROs, CDMOs, medical device companies, laboratory suppliers, regulatory technology providers, and related commercial teams.
Traditional CRMs help teams manage records. DOSSIRI is designed to help regulated-industry sales professionals accumulate account intelligence, assess opportunities, and prepare for customer interactions using evidence-based workflows.
DOSSIRI is built around the principle that commercial decisions should be grounded in evidence. Intelligence should be traceable, confidence should be visible, and users should understand where information comes from before acting on it.
No. DOSSIRI is compliance-aware, not compliance-management software. It is not a QMS, validation platform, or regulatory management system.
No. DOSSIRI supports organizations that operate in regulated environments, but DOSSIRI is not a 21 CFR Part 11 system and is not intended to serve as a validation, quality, or compliance management platform.
No. DOSSIRI is not intended to store protected health information (PHI) or patient data.
DOSSIRI is designed to support commercial workflows, account intelligence, opportunity assessment, and pre-call preparation for regulated-industry sales teams.
DOSSIRI is being positioned around CRM records such as accounts, contacts, and deals. Specific migration workflows and availability are part of launch packaging, not published pricing-page commitments.
Some organizations may choose DOSSIRI as their primary CRM. Others may evaluate it alongside existing workflows. The goal is not to replicate generic CRM software—it is to provide CRM and intelligence workflows built specifically for regulated-industry sales teams.
Final pricing details are not published yet. The current website does not publish package pricing, per-seat pricing, free-trial terms, or subscription billing details.
Request access for launch updates. Final pricing and billing details are not published yet.
Request Early Access →